NPPB and acute coronary syndrome: The combined use of cardiac biomarkers, such as relatively low peak troponin levels, markedly elevated NT-proBNP, and diagnostic ratios including copeptin/NT-proBNP, along with advanced imaging modalities, provides a robust framework for differentiating TTS from acute coronary syndromes.